The Translational Genomics Research Institute, part of City of Hope, has announced the appointment of John D. Fryer as a professor in the Division of Bioinnovation and Genome Sciences and director of the newly established Center for Accelerated Nanotherapeutics.
An anonymous donor made a $50 million gift to Duke University Health System toward the development of a proton beam therapy center. The donation is the largest philanthropic gift received by Duke University Health System.
Washington University researchers at Siteman Cancer Center received a $10.8 million grant throughNCI’s Specialized Programs of Research Excellence. Led by principal investigator Daniel C. Link, the five-year grant is a renewal of a previous SPORE grant in leukemia.
CureSearch for Children’s Cancer awarded a $225,000 research grant to John Prensner, a physician-scientist at the University of Michigan, to advance research on atypical teratoid/rhabdoid tumors. One of the most aggressive and fatal brain cancers affecting infants and toddlers, ATRT has limited treatment options and devastating outcomes, with more than half of cases proving fatal.
The Association of Cancer Care Centers Board of Trustees released the following statement regarding the firefighters currently battling wildfires in Los Angeles County:
A recent report showed that UPMC Hillman Cancer Center generated $3.98 billion in total economic impact in Pennsylvania through its clinical, research, and educational missions in 2023.
Lucio Miele will serve as director of the LSU LCMC Health Cancer Center. This announcement follows the current director Joe Ramos’ acceptance of an executive leadership position at the Lundquist Institute in California.
NRG Oncology recently announced the creation of a new Theranostics Subcommittee, as well as two leadership role updates within the organization’s current committees.
Sulma Mohammed was named co-leader of the University of Florida’s Health Cancer Center’s Cancer Control and Population Sciences research program. She will also serve as co-director of the NCI-funded Florida-California Cancer Research, Education and Engagement CaRE2 Health Equity Center.
José Larios, a transplant hematologist, joined The Barbara Ann Karmanos Cancer Institute as a member of the bone marrow and stem cell transplant and hematology oncology multidisciplinary teams at Karmanos. He specializes in treating leukemia and lymphoma blood cancers, including Hodgkin and non-Hodgkin lymphomas. He began seeing patients at the Karmanos Cancer Center in Detroit in August 2024.
